Showing Results for: “type 1 diabetes”

Written by Pamela Roller, who lives with type 1 diabetes. Dedicated to all diabetics and their families. On November 14th every year A day diabetics hold so dear Sadly, diabetes has been on the rise Many have it, but don’t realize To stop diabetes, make people more aware Diabetics are not alone; others do care Internationally, we all must unite To hope, survive, and to win the fight The diabetes ribbon and symbol are blue Diabetics need a cure and support too Blue for the sky we all share In a circle for unity everywhere Grateful for the co-founders of insulin To treat the disease of friends

Initial data indicate that children presented with higher acuity compared to the previous year New data show that the incidence and acuity of type 2 diabetes in children increased significantly during the peak of the COVID-19 pandemic, with more pediatric patients hospitalized from March to December 2020 compared to the same time period in 2019. Findings from the retrospective chart review were presented as a late-breaking poster session at the virtual 81st Scientific Sessions of the American Diabetes Association ® (ADA). Stay-at-home orders due to the COVID-19 pandemic exacerbated risk

Data Addresses Gaps in Preventive Prescriptions Therapy, Emphasizing the Importance of Multifaceted Interventions Today, findings from the COORDINATE-Diabetes trial demonstrated that multi-disciplinary care between cardiologists, diabetes specialists and other team members can significantly increase the prescriptions of evidence-based therapies to help treat patients with both type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD), commonly known as heart disease. The trial was presented as a late-breaking symposium today at the 83rd Scientific Sessions of the American

American Diabetes Association Symposium Demonstrates Benefits of Once Weekly Drug for Weight Loss and Glycemic Control Today, findings from SURMOUNT-2, a study of tirzepatide in participants with type 2 diabetes who have obesity were announced, demonstrating more weight loss in individuals with diabetes than any other medication to date. The results were presented at the 83rd Scientific Sessions of the American Diabetes Association ® (ADA) in San Diego, CA and were simultaneously published in The Lancet . Obesity impacts 650 million people worldwide including nearly half of all Americans and

The Teplizumab Prevention Trial has given validity to the concept that immune therapy can delay the diagnosis of type 1 diabetes (T1D), according to findings presented at a symposium entitled “New Therapeutic Approaches and Insights for Type 1 Diabetes” today at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions® at the Moscone Convention Center in San Francisco. Family members of someone with T1D have a 15 times greater risk of developing T1D than individuals from the general population. Testing can determine the presence of autoantibodies, indicating risk for T1D, and the

First-of-Its-Kind Study Compares Open-Source Automated Insulin Delivery to Sensor-Augmented Pump Therapy Results from the CREATE Trial demonstrated open-source automated insulin delivery (AID) systems are a safe and effective therapy for people with type 1 diabetes. Findings from the randomized controlled trial (RCT) comparing open-source AID to sensor-augmented pump therapy (SAPT) were presented today at the 82nd Scientific Sessions of the American Diabetes Association ® (ADA). Open-source AID systems were developed to reduce the burden of living with diabetes by combining an insulin pump

Marsha, from Birmingham, Alabama, was diagnosed with diabetes at age 28. This is her story: I became very ill at the age of 28 years old. I was rushed to the hospital. The ER doctor rushed into my room and asked if I knew that I was diabetic. I did not!!! I had no idea what diabetes even was, but over that one-week span of being in the hospital in ICU on an insulin drip/IV, I quickly learned about a disease that would take precedence over my life. I was sent home with a ton of information and a ton of medicine, such as two different types of insulin, several needles, booklets of how I should

As a no-cost lifestyle change program, Project Power empowers adults and children to reduce their risk or manage and thrive with type 2 diabetes.

Learn about the four types of fat and their impact on your health. Find out what fat is, how it functions in our bodies, and how to incorporate the right types of fat into your diet for optimal health.

Connor O’Hara is a third-year graduate student in the Department of Medicinal Chemistry, School of Pharmacy at Virginia Commonwealth University (VCU). Connor didn’t let his diabetes slow him down; in fact, he uses it as inspiration for his career! Calling diabetes a foundation for his pursuit of knowledge, Connor says “let us all be compelled to help drive and support the research and innovation that will bring new therapies and cures, and even turn #Type1 into #TypeNone.” On April 23, 2007 I was rushed into intensive care at MCV Hospital at VCU in Richmond, Virginia presenting with diabetic